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Background:  The present study assessed whether treating non-low density lipoproteins (LDL) in postmenopausal women with niacin in addition to 
statin would improve endothelial function and vascular inflammation.
Methods:  We conducted a randomized, double-blind, placebo-controlled trial of 16 weeks of niacin (N) versus placebo (PL) in 43 women (mean 
age, 67 ± 9 years) previously on statin therapy with LDL 90 -135 mg/dl and triglycerides > 150 mg/dl. The study outcomes included lipoprotein 
levels, vascular inflammation assessed by high sensitivity C-reactive protein (hsCRP), Interleukin 6 (IL-6), Tumor Necrosis Factor _ (TNF-_) and 
endothelial function, assessed as brachial artery flow mediated dilation (FMD). Repeated measures ANCOVA and regression analysis were performed 
on data.
Results:  While N group significantly increased HDL and decreased LDL as compared to PL; there were no group differences in FMD, hsCRP, IL-6 or 
TNF-_ at exit. Importantly, there was a significant positive correlation between change in FMD and age (Figure) such that change in FMD with lipid 
lowering therapy (from pre to post) was greater with increasing age, independent of treatment group. This effect persisted even when the model was 
adjusted for covariates.
Conclusions:  Lipid lowering therapy with combination niacin and statin exerts an age-related effect on endothelial function in women. 
Specifically, older, predominantly postmenopausal women demonstrate relatively greater endothelial benefit.
